Infant Colonization With Methicillin-Resistant Staphylococcus aureus or Vancomycin-Resistant Enterococci Preceding Neonatal Intensive Care Unit Discharge

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e144-e148. doi: 10.1093/jpids/pix003.

Abstract

Rates of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and/or vancomycin-resistant enterococci (VRE) were determined for 1320 infants within 7 days of neonatal intensive care unit discharge. Overall, 4% and 1% of the infants were colonized with MRSA or VRE, respectively. Predictors identified in fixed-effects models were surgery during hospitalization (for MRSA colonization) and prolonged antimicrobial treatment (for VRE colonization).

Keywords: MRSA; VRE; antimicrobial resistance; colonization; risk factors.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Enterococcus / drug effects
  • Female
  • Hospitalization
  • Humans
  • Infant, Newborn
  • Intensive Care Units, Neonatal*
  • Male
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification*
  • Microbial Sensitivity Tests
  • Prospective Studies
  • Risk Factors
  • Staphylococcal Infections / epidemiology*
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / pathogenicity
  • United States
  • Vancomycin Resistance
  • Vancomycin-Resistant Enterococci / drug effects
  • Vancomycin-Resistant Enterococci / isolation & purification*

Substances

  • Anti-Bacterial Agents